โ Home
© 2024 - 2025 InsightfulValue.com. All rights reserved.
โน๏ธ Info
๐งพ At a Glance ๐ Core Facts ๐๏ธ Products/Services โญ Ratings ๐งโ๐ผ Executives ๐ฌ My Comments๐ก Analytics
๐ Insights (1) ๐ข Company Q&A (464) ๐ ๏ธ Industry Q&A (98) ๐ Competitors ๐ Price Low ๐ Price Swings โก SWOT ๐๏ธ PEST ๐ Porter's Five Forces โจ Score Positive โ ๏ธ Risk Assessment ๐งฉ Segmentation ๐ ถ Google Links๐ Ratios
๐ฐ Margins ๐ Financial Ratios ๐ฑ Growth ๐ Enterprise Value ๐ Key Metrics ๐ต Dividends๐ง Tools
โ Due Diligence๐ข Press Releases
Date | Press release |
---|---|
2025-05-28 06:50:00 | Bd To Initiate Real-world Patient Data Registry For The Rotarexโข Atherectomy System In Treatment Of Peripheral Artery Disease Franklin lakes, n.j. , may 28, 2025 /prnewswire/ --ย bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced plans to initiate a patient data registry for the rotarexโข atherectomy system to measure real-world outcomes for patients with peripheral artery disease (pad). |
2025-05-27 16:15:00 | Bd To Present At Goldman Sachs 46th Annual Global Healthcare Conference Franklin lakes, n.j. , may 27, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that it will present at the goldman sachs 46th annual global healthcare conference on monday, june 9, 2025 at 2:00 pm eastern time. |
2025-05-21 06:38:00 | Cancer Patients Face Elevated Risk Of Carrying Antimicrobial Resistant โsuperbugsโ Franklin lakes, n.j. , may 21, 2025 /prnewswire/ -- first-of-their-kind studies published inย the lancet oncology 1 and cancer medicine 2 provide new data showing that cancer patients in both hospital and outpatient settings are at a substantially higher risk of developing antimicrobial resistant (amr) infections compared to all other non-cancer patients. |
2025-05-12 09:00:00 | Bd To Announce Financial Results For Its Third Quarter Of Fiscal 2025 Franklin lakes, n.j. , may 12, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced that bd management will host an audio webcast at 8 a.m. |
2025-05-01 06:30:00 | Bd Reports Second Quarter Fiscal 2025 Financial Results Revenue of $5.3 billion increased 4.5% as reported, 6.0% currency-neutral and 0.9% organic gaap and adjusted diluted eps of $1.07 and $3.35, respectively company updates full-year fiscal 2025 guidance and provides estimated tariff impact franklin lakes,ย n.j., may 1, 2025 /prnewswire/ -- bd (becton, dickinson and company) (nyse: bdx), a leading global medical technology company, today announced results for its fiscal 2025 second quarter, which ended marchย 31, 2025. |
2025-04-30 16:15:00 |
|
2025-04-29 16:20:00 |
|
2025-04-23 06:50:00 |
|
2025-04-21 07:35:00 |
|
2025-04-03 16:15:00 |
|
2025-03-31 06:50:00 |
|
2025-03-27 16:15:00 |
|
2025-03-20 06:50:00 |
|
2025-02-05 16:30:00 |
|
2025-01-28 16:15:00 |
|

๐ฐ Browse additional press releases for Becton Dickinson and Company!
Sign up for free or log inโ๏ธ Sign up to get "The Checklist Value Investor โ A Smarter Way to Pick Stocks" for free